Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice

(2020) Ting-Ting Cai et al.   Frontiers in Pharmacology

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature

(2019) Ivana Milosevic et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice

(2019) Jialin Xu et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells

(2019) Haider Rasheed Alrafas et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Alterations of Bile Acids and Gut Microbiota in Obesity Induced by High Fat Diet in Rat Model

(2019) Hong Lin et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation

(2019) Fei Chen et al.   HEPATOLOGY

Blood metabolome predicts gut microbiome α-diversity in humans

(2019) Tomasz Wilmanski et al.   NATURE BIOTECHNOLOGY

Effects of Quercetin and Resveratrol on in vitro Properties Related to the Functionality of Potentially Probiotic Lactobacillus Strains

(2019) Aldeir Sabino dos Santos et al.   Frontiers in Microbiology

The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota

(2019) Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

(2019) Gordon I. Smith et al.   JOURNAL OF CLINICAL INVESTIGATION

The functional genomic studies of resveratrol in respect to its anti-cancer effects

(2018) Lukasz Huminiecki et al.   BIOTECHNOLOGY ADVANCES

Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin

(2018) Wenfeng Li et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease

(2018) Emma T. Saltzman et al.   Frontiers in Microbiology

Sinapic acid and resveratrol alleviate oxidative stress with modulation of gut microbiota in high-fat diet-fed rats

(2018) Chen Yang et al.   FOOD RESEARCH INTERNATIONAL

Resveratrol, Metabolic Syndrome, and Gut Microbiota

(2018) Alice Chaplin et al.   Nutrients

Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals

(2018) Bonggi Lee et al.   Journal of Immunology Research

Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet

(2018) Cheng Kong et al.   NUTRITION

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment

(2017) Vincent Wai-Sun Wong et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Systematic Review and Meta-Analysis Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis

(2017)   Journal of Gastrointestinal and Liver Diseases

Treatment of NAFLD with diet, physical activity and exercise

(2017) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials

(2017) Tomasz Charytoniuk et al.   NUTRITION

Weight-loss interventions and gut microbiota changes in overweight and obese patients: a systematic review

(2017) F. B. Seganfredo et al.   Obesity Reviews

Gut microbiome interactions with drug metabolism, efficacy, and toxicity

(2017) Ian D. Wilson et al.   Translational Research

A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota

(2017) Le Zhao et al.   Food & Function

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)

(2017) Qian Chen et al.   Nutrients

Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome

(2016) Miranda M. Sung et al.   DIABETES

Association of Intestinal Microbiota with Metabolic Markers and Dietary Habits in Patients with Type 2 Diabetes

(2016) Yoshiharu Yamaguchi et al.   DIGESTION

The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials

(2016) Haohai Huang et al.   Obesity Reviews

The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study

(2015) Forouzan Faghihzadeh et al.   BRITISH JOURNAL OF NUTRITION

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?

(2015) Mohamed Asrih et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

World Gastroenterology Organisation Global Guidelines

(2014) Douglas R. LaBrecque et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Phylogeny, culturing, and metagenomics of the human gut microbiota

(2014) Alan W. Walker et al.   TRENDS IN MICROBIOLOGY

Fecal microbial metabolism of polyphenols and its effects on human gut microbiota

(2013) Shanthi G. Parkar et al.   ANAEROBE

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients

(2013) Ali Movahed et al.   Evidence-based Complementary and Alternative Medicine

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

(2013) Morgan G I Langille et al.   NATURE BIOTECHNOLOGY

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation

(2013) João Marcus Oliveira Andrade et al.   NUTRITION

Diversity, stability and resilience of the human gut microbiota

(2012) Catherine A. Lozupone et al.   NATURE

High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway

(2012) Kyung-Ah Kim et al.   PLoS One

Bioavailability of resveratrol

(2011) Thomas Walle   Annals of the New York Academy of Sciences

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

(2011) Pál Brasnyó et al.   BRITISH JOURNAL OF NUTRITION

Insulin signaling to hepatic lipid metabolism in health and disease

(2011) Karla F. Leavens et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Changes in white adipose tissue metabolism induced by resveratrol in rats

(2011) Goiuri Alberdi et al.   Nutrition & Metabolism

Responses of Gut Microbiota to Diet Composition and Weight Loss in Lean and Obese Mice

(2011) Yann Ravussin et al.   Obesity

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models

(2010) E F Murphy et al.   GUT

Determination of Dihydroresveratrol in Rat Plasma by HPLC

(2010) M. Emília Juan et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

In Vitro Bioconversion of Polyphenols from Black Tea and Red Wine/Grape Juice by Human Intestinal Microbiota Displays Strong Interindividual Variability

(2010) Gabriele Gross et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Gut Microbiota in Health and Disease

(2010) Inna Sekirov et al.   PHYSIOLOGICAL REVIEWS

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

(2008) Herbert Tilg et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM